Information Provided By:
Fly News Breaks for February 5, 2016
VRTX
Feb 5, 2016 | 06:06 EDT
Leerink analyst Geoffrey Porges resumed coverage of Vertex Pharmaceuticals with an Outperform rating and $131 price target.